Advertisement
News
Subscribe to MDT Magazine News

Quest starts tender offer for Celera

March 28, 2011 8:45 am | by The Associated Press | Comments

Quest Diagnostics has opened its tender offer in an attempt to buy Celera Corp. for $671 million, the company said Monday.The medical laboratory operator said earlier this month it would pay $8 cash for each share of Calera, a premium of 28 percent at the time. The deal price includes Celera's...

Reduced Hours for Trainees Has Had Little Effect in U.S.

March 28, 2011 8:32 am | by Diagnostic Imaging | Comments

HealthDay News - Shorter work week for doctors in training has had little impact, positive or negative, on patient safety

TOPICS:

Alnylam lands $10M pay from Takeda

March 28, 2011 6:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Alnylam Pharmaceuticals Inc. has pulled in a $10 million tech transfer payment from Japanese drug maker Takeda Pharmaceutical Co. Ltd., related to a May 2008 deal between the two companies potentially worth up to $1 billion.

Advertisement

Irinotecan Hydrochloride Injection: Recall - Fungal Microbial Contaminant

March 28, 2011 6:37 am | by U.S. Food & Drug Administration | Comments

Non-sterility of a chemotherapeutic product administered via the intravenous route has the potential to result in infections which could be fatal, especially in patients who are immunocompromised.

Summary Information for: Elana Surgical KitHUD

March 28, 2011 6:36 am | by U.S. Food & Drug Administration | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for Elana Surgical KitHUD (H080005).

Torrance Dentist, Dr. Robert Mondavi, Now Uses Digital X-Rays for Comfort and Safety of the Patients

March 28, 2011 6:34 am | by Bio-Medicine.Org | Comments

TORRANCE, Calif., March 28, 2011 /- Cosmetic dentist in Torrance , Dr. Robert Mondavi, DDS, utilizes the latest digital technologies in dental science to provide a safe and comfortable visit for area patients. The speed and accuracy of digital x-ray systems are revolutionizing dental...

TOPICS:

Chimerix Appoints Timothy W. Trost Senior Vice President, Chief Financial Officer

March 28, 2011 6:33 am | by Bio-Medicine.Org | Comments

DURHAM, N.C., March 28, 2011 /- Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, announced today that Timothy W. Trost has joined the company as Senior Vice President, Chief Financial Officer. Mr. Trost brings to Chimerix more than 30 years of...

TOPICS:

Novavax 4Q loss narrows on costs

March 28, 2011 5:45 am | by The Associated Press | Comments

Vaccine maker Novavax Inc. on Monday reported a narrower fourth-quarter loss as research and other expenses fell.Novavax is testing vaccines for flu strains including swine flu, and other respiratory diseases.Novavax said it lost $6.3 million, or 6 cents per share, compared with a loss of $10.3...

Advertisement

Citalopram And Finasteride by Greenstone: Recall - Possible Mislabeling

March 28, 2011 5:37 am | by U.S. Food & Drug Administration | Comments

Bottles labeled as citalopram may contain finasteride.

Everist Genomics Announces Worldwide Availability of OncoDefenderâ„¢-CRC

March 28, 2011 5:35 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., March 28, 2011 /- Everist Genomics today announced the worldwide commercial availability of its OncoDefender-CRC colorectal cancer assay, the first and only molecular prognostic test capable of accurately predicting the risk of recurrence of cancer in patients previously...

TOPICS:

Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting

March 28, 2011 5:35 am | by Bio-Medicine.Org | Comments

NEW YORK, March 28, 2011 /- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) (the "Company") today announced that two abstracts on KRX-0401 (perifosine) will be presented at the upcoming 102nd annual meeting of the American Association for Cancer Research (AACR) to be held in Orlando,...

TOPICS:

Interventional radiologists take lead on reducing disability from dangerous blood clots

March 28, 2011 5:33 am | by EurekAlert | Comments

(Society of Interventional Radiology) Deep vein thrombosis, or DVT: it's more than just a one-time complication from taking a long plane ride. The Society of Interventional Radiology wants individuals to know the risk factors for this very serious condition, which can lead to...

TOPICS:

Optimer Pharmaceuticals Announces Presentation at Upcoming SHEA Annual Meeting Regarding Hospital CDI Patients at Risk of Recurrence and Mortality

March 28, 2011 5:32 am | by Bio-Medicine.Org | Comments

SAN DIEGO, March 28, 2011 /- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ) announced that data highlighting the burden of Clostridium difficile infection using National health insurance claims and survey databases will be presented on April 2, 2011 at the 21st Annual Scientific Meeting of...

TOPICS:

Quest Diagnostics Commences Tender Offer for Acquisition of Celera

March 28, 2011 5:32 am | by Bio-Medicine.Org | Comments

MADISON, N.J., March 28, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, announced today it has commenced a tender offer through its wholly owned subsidiary, Spark Acquisition Corporation, for all of the...

TOPICS:

Graymark Healthcare Reports Full Year 2010 Results

March 28, 2011 5:32 am | by Bio-Medicine.Org | Comments

OKLAHOMA CITY, March 28, 2011 /- Graymark Healthcare, Inc. (Nasdaq: GRMH ), the nation's second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), reported financial results for the fiscal year ended December 31, 2010....

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading